Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of prilocaine and fentanyl is an investigational anesthetic regimen being studied for spinal anesthesia in geriatric patients. Prilocaine is a small molecule local anesthetic of the amide type that functions by binding to and inhibiting voltage-gated sodium channels on the internal surface of nerve cell membranes. This action prevents the influx of sodium ions, thereby blocking the initiation and conduction of nerve impulses and resulting in local anesthesia. Fentanyl is a potent synthetic opioid analgesic that acts primarily as an agonist at the mu-opioid receptor (MOR). When administered intrathecally alongside a local anesthetic, fentanyl provides synergistic analgesia, potentially improving the quality of the sensory block and allowing for a reduction in the dose of the local anesthetic, which is particularly beneficial in elderly populations to minimize hemodynamic instability. This specific combination, utilizing hyperbaric prilocaine 2% (Takipril), is being evaluated by Cairo University in various dosing cohorts (30 mg, 40 mg, and 50 mg of prilocaine with 25 µg of fentanyl) for day-case lower abdominal and urologic surgeries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on prilocaine + fentanyl.